Showing 34,870 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Hepatitis C treatment

Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows

News
16 January 2018
PrEP programmes & uptake

Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

News
15 January 2018
Viral load

Faster action on adherence is needed after viral load becomes detectable, researchers warn global treatment programmes

News
12 January 2018
The search for a cure

NIH study supports use of short-term HIV treatment interruption in clinical trials

Editor's pick
National Institutes of Health
11 January 2018
Global health targets

London signs up to the HIV Fast-Track Cities initiative

News
11 January 2018
Combatting stigma

Report highlights the need to clean the conversation around drug use

Editor's pick
The Globe and Mail
11 January 2018
Combatting stigma

Man with HIV goes public in powerful Facebook post in bid to tackle stigma

Editor's pick
Daily Mirror
11 January 2018
Contraception

Withdrawing Depo-Provera contraceptives would result in more lives lost than HIV infections prevented

News
11 January 2018
PrEP

'Thinking About Sex?' DC Uses Racy Ad to Promote Anti-HIV Drug

Editor's pick
NBC4 Washington
10 January 2018
Global health targets

London joins Fast-Track Cities initiative to reduce new HIV infections

Editor's pick
Mayor of London
10 January 2018
Government, leadership & policy

Experts worry about consequences of Trump’s HIV/AIDS council firings

Editor's pick
Healio
10 January 2018
Pharmaceutical industry

Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States

Editor's pick
Teva press release
10 January 2018
Harm reduction

HIV spike linked to injection-drug use hits Cincinnati area

Editor's pick
USA TODAY
10 January 2018
Injectable & long-acting HIV treatment

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

News
9 January 2018
Hepatitis C treatment

India to launch national program to control viral hepatitis and aims to negotiate lower drug prices

Editor's pick
Pharma Letter
9 January 2018
PrEP

Usage remains low for pill that can prevent HIV infection

Editor's pick
ABC News
9 January 2018
Undetectable viral load & treatment as prevention

Do you speak U=U? Talking to patients about treatment as prevention

Editor's pick
BHIVA
9 January 2018
Pharmaceutical industry

Brexit: Fears of disruption to flow of medicines means UK must stay under EU regulation, say government figures

Editor's pick
The Independent
9 January 2018
Bone & joint problems

Twice the rate of bone loss among ART-treated women than men

News
9 January 2018
PrEP

Kenya: HIV prevention pill yet to catch on

Editor's pick
Daily Nation
8 January 2018
Transgender people

Trans Lives Matter

Editor's pick
Poz
8 January 2018
New & experimental HIV treatments

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

Editor's pick
Yale News
8 January 2018
New & experimental HIV treatments

FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection

Editor's pick
Merck press release
8 January 2018
Hepatitis C treatment

England: 25,000 Hepatitis C patients receive new treatments

Editor's pick
NHS England
8 January 2018